IOV-2001

N/A

Report date: 2025/12/25 20:00:14

Base Information

Drug NameIOV-2001
Drug Alias NamePeripheral blood lymphocytesIOV-2001 (Autologous, Non-Genetically Modified, Polyclonal T-Cell Product)Autologous PBLIOV-2001
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicity
TargetsNot applicable
Therapy Area/IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIovance Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIovance Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A